000963 (000963) News
Follow 000963 (000963) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Heidelberg Pharma and Huadong expand antibody-drug conjugate collaboration
Heidelberg Pharma and Huadong Medicine signed an additional collaboration agreement to jointly develop new antibody drug conjugates.
EQUITY | Aug 28, 2026, 08:51 AM UTC
L
Heidelberg Pharma and Huadong get NMPA nod for HDP-101 China trial
Heidelberg Pharma and Huadong Medicine received NMPA approval for the HDP-101 clinical trial in China, according to TradingView News.
GEOPOLITICS | Aug 26, 2026, 04:32 PM UTC